Abbott India to stop selling Xience Alpine drug-eluting stent in India

26 Apr 2018 Evaluate

Abbott India has done with all the necessary formalities to stop selling its Xience Alpine drug-eluting stent in India. Hence, the company will not be selling the device in the country from April 26, 2018.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott India Share Price

26470.00 0.05 (0.00%)
16-Feb-2026 12:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1695.50
Dr. Reddys Lab 1267.40
Cipla 1350.00
Zydus Lifesciences 906.50
Lupin 2220.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×